Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $2,056,939 (100.0% shares, 0.0% debt)

Holdings (39)

BMRN BIOMARIN PHARMACEUTICAL INC 10.9%
Value ($000) $223,245 Shares 2,606,485 Est. Cost $80.19 Unrealized +6.7%
INSM INSMED INC 9.8%
Value ($000) $202,007 Shares 7,890,917 Est. Cost $17.16 Unrealized +62.3%
ABIOMED INC 8.9%
Value ($000) $183,998 Shares 706,354 Est. Cost $37.80 Unrealized
SAGE THERAPEUTICS INC 7.1%
Value ($000) $145,562 Shares 795,031 Est. Cost $48.62 Unrealized
ALEXION PHARMACEUTICALS INC 6.5%
Value ($000) $134,095 Shares 1,023,780 Est. Cost $121.54 Unrealized
STAA STAAR SURGICAL CO 6.1%
Value ($000) $124,485 Shares 4,237,051 Est. Cost $13.06 Unrealized +121.0%
UTHR UNITED THERAPEUTICS CORP DEL 5.9%
Value ($000) $121,211 Shares 1,552,792 Est. Cost $88.73 Unrealized +5.4%
FOLD AMICUS THERAPEUTICS INC 4.7%
Value ($000) $97,298 Shares 7,796,299 Est. Cost $7.54 Unrealized +68.3%
IMMUNOMEDICS INC 4.5%
Value ($000) $92,607 Shares 6,676,755 Est. Cost $13.38 Unrealized
EPIZYME INC 4.2%
Value ($000) $87,035 Shares 6,935,074 Est. Cost $15.12 Unrealized
WRIGHT MED GROUP N V 4.0%
Value ($000) $82,643 Shares 2,771,394 Est. Cost $23.42 Unrealized
AIMMUNE THERAPEUTICS INC 3.9%
Value ($000) $79,711 Shares 3,828,564 Est. Cost $22.84 Unrealized
CLOVIS ONCOLOGY INC 3.7%
Value ($000) $76,451 Shares 5,141,304 Est. Cost $51.30 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.5%
Value ($000) $71,226 Shares 5,055,050 Est. Cost $11.21 Unrealized +42.0%
ACAD ACADIA PHARMACEUTICALS INC 3.0%
Value ($000) $61,714 Shares 2,308,803 Est. Cost $27.34 Unrealized -6.6%
ALGN ALIGN TECHNOLOGY INC 2.0%
Value ($000) $40,372 Shares 147,505 Est. Cost $114.31 Unrealized +164.2%
EXAS EXACT SCIENCES CORP 1.8%
Value ($000) $37,169 Shares 314,889 Est. Cost $13.61 Unrealized +640.1%
AMAG PHARMACEUTICALS INC 1.6%
Value ($000) $33,721 Shares 3,375,506 Est. Cost $29.07 Unrealized
KARYOPHARM THERAPEUTICS INC 1.5%
Value ($000) $31,521 Shares 5,262,263 Est. Cost $17.42 Unrealized
MOMENTA PHARMACEUTICALS INC 1.2%
Value ($000) $23,895 Shares 1,919,313 Est. Cost $14.06 Unrealized
ALDER BIOPHARMACEUTICALS INC 1.1%
Value ($000) $21,911 Shares 1,861,630 Est. Cost $11.48 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 0.9%
Value ($000) $17,866 Shares 1,405,680 Est. Cost $28.90 Unrealized -20.3%
GILD GILEAD SCIENCES INC 0.6%
Value ($000) $11,884 Shares 175,900 Est. Cost $62.02 Unrealized -18.1%
PRTA PROTHENA CORP PLC 0.6%
Value ($000) $11,717 Shares 1,108,510 Est. Cost $32.98 Unrealized -68.9%
RIGEL PHARMACEUTICALS INC 0.5%
Value ($000) $10,403 Shares 3,985,945 Est. Cost $3.40 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.5%
Value ($000) $10,053 Shares 866,666 Est. Cost $13.76 Unrealized +5.8%
CELGENE CORP 0.5%
Value ($000) $9,880 Shares 106,883 Est. Cost $89.02 Unrealized
DICERNA PHARMACEUTICALS INC 0.3%
Value ($000) $5,226 Shares 331,813 Est. Cost $5.39 Unrealized
ALIMERA SCIENCES INC 0.1%
Value ($000) $2,682 Shares 3,013,793 Est. Cost $4.88 Unrealized
ZOGENIX INC 0.1%
Value ($000) $1,410 Shares 29,500 Est. Cost $13.36 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value ($000) $1,391 Shares 123,686 Est. Cost $6.71 Unrealized +43.6%
SUNESIS PHARMACEUTICALS INC 0.0%
Value ($000) $845 Shares 1,162,473 Est. Cost $4.37 Unrealized
MARINUS PHARMACEUTICALS INC 0.0%
Value ($000) $520 Shares 125,321 Est. Cost $4.17 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value ($000) $441 Shares 73,500 Est. Cost $7.53 Unrealized 0.0%
SOPHIRIS BIO INC 0.0%
Value ($000) $209 Shares 247,000 Est. Cost $2.60 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value ($000) $206 Shares 77,044 Est. Cost $8.90 Unrealized
MINERVA NEUROSCIENCES INC 0.0%
Value ($000) $204 Shares 36,319 Est. Cost $5.62 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value ($000) $67 Shares 10,137 Est. Cost $3.55 Unrealized
HISTOGENICS CORP 0.0%
Value ($000) $58 Shares 302,922 Est. Cost $11.00 Unrealized